-
Blockchain And Healthcare Convene In Nashville For Distributed: Health
Clinical Informatics News | Leaders in the healthcare and blockchain spaces came together for the third annual Distributed: Health conference in Nashville, Tennessee. Investors, healthcare providers, and researchers in on a key question: Where are we in the integration of blockchain and distributed ledger technology into the healthcare space?
Nov 8, 2018
-
Why Doctors Hate Their Computers
The New Yorker | Atul Gawande on the promise of digitization to make medical care easier and more efficient, and whether screens may be coming between doctors and patients.
Nov 8, 2018
-
It’s About Time That Medicare Advantage Stops Being A Disadvantage For Clinical Research Participants
Clinical Informatics News | It’s About Time | Norman Goldfarb discusses the problems and confusions surrounding Medicare Advantage plans and clinical trials with Kelly Willenberg, Manager of Kelly Willenberg & Associates.
Nov 7, 2018
-
The VA Shadow Rulers' Signature Program Is "Trending Towards Red"
ProPublica | A $10 billion technology upgrade championed by Jared Kushner and the Mar-a-Lago trio is at risk of failing the VA's 7 million patients.
Nov 2, 2018
-
New Head For Renamed Icahn Institute At Mount Sinai
Clinical Informatics News | Mount Sinai has named a new head for its Icahn Institute, and renamed the effort the Icahn Institute for Data Science and Genomic Technology. Adam Margolin will lead the new enterprise-wide program, whose 10-year plan includes 55 new faculty and staff, new computational infrastructure, and an educational program to train master’s students and PhDs in biomedical data science.
Nov 2, 2018
-
BioIVT, Veeva Systems, PAREXEL, And More: News From October 2018
Clinical Informatics News | October was full of exciting news in the clinical trial and healthcare community, including partnerships, products, and promotions from BioIVT, Veeva Systems, PAREXEL, and more.
Oct 31, 2018
-
Millions Excluded By Language Barrier From Clinical Trials
NPR.org | In the U.S., Alzheimer's clinical trials are largely limited to fluent English speakers, which leaves millions of patients without the opportunity to participate and scientists without diverse data.
Oct 31, 2018
-
He Promised to Restore Damaged Hearts. Harvard Says His Lab Fabricated Research.
The New York Times | Findings that would have revolutionized treatment of heart attacks were based on falsified and fabricated data, revealing weaknesses in medical research.
Oct 29, 2018
